- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02147275
Monitoring Hypertensive Patients's Cerebral Oxygen Saturation (MHPCOS)
November 10, 2014 updated by: Li Hongyi, Huazhong University of Science and Technology
Monitoring Cerebral Oxygen Saturation in Hypertensive Patients Undergoing Major Abdominal Surgery
The purpose of this study is to determine whether there is a significant decrease in cerebral oxygen saturation in hypertensive patients undergoing major abdominal surgery and their correlation with standard monitoring parameters.
Study Overview
Status
Completed
Study Type
Observational
Enrollment (Actual)
41
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Hubei
-
Wuhan, Hubei, China, 430030
- Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
30 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
patients scheduled for major abdominal surgery such as gastrectomy, colon resection ,liver resection and duodenocephalo-pancreasectomy
Description
Inclusion Criteria:
- patients have hypertension more than 3 year,whether well-controlled or uncontrolled,
- scheduled for major abdominal surgery for at least 2 h
- under general anesthesia
- American Society of Anesthesiologists(ASA)physical status : II ~ III
- Age > 30
Exclusion Criteria:
- pre-existing cerebral pathology for example episodes of cerebral ischemia or stroke;
- ASA physical status >IV
- hepatic failure
- renal failure
- preoperative Mini-Mental State Examination (MMSE) score less than 24
- a history of cardiovascular surgery or craniotomy
- cardiac failure
- respiratory failure
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
hypertension disease
patients have hypertension disease, whether well-controlled or uncontrolled, more than 3 year
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
decreases in cerebral oxygen saturation (rSO2) during the surgery
Time Frame: every 5 minutes throughout the surgery
|
every 5 minutes throughout the surgery
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change from baseline in Mini-Mental State Exam (MMSE) perioperative period
Time Frame: Baseline, 4 day after surgery
|
Baseline, 4 day after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Peng Wang, MD PHD, Vice Director
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2014
Primary Completion (Actual)
November 1, 2014
Study Completion (Actual)
November 1, 2014
Study Registration Dates
First Submitted
May 22, 2014
First Submitted That Met QC Criteria
May 23, 2014
First Posted (Estimate)
May 26, 2014
Study Record Updates
Last Update Posted (Estimate)
November 11, 2014
Last Update Submitted That Met QC Criteria
November 10, 2014
Last Verified
November 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Necrosis
- Cardiovascular Diseases
- Vascular Diseases
- Cerebrovascular Disorders
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Signs and Symptoms, Respiratory
- Infarction
- Stroke
- Brain Infarction
- Hypoxia
- Hypertension
- Brain Ischemia
- Ischemia
- Cerebral Infarction
- Hypoxia, Brain
Other Study ID Numbers
- TJH-AD-12888
- 75888 (Other Identifier: Tongji hospital)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
Franz Rischard, DOAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway...Not yet recruitingPulmonary Hypertension | Pulmonary Arterial Hypertension (PAH)United States
-
Abant Izzet Baysal UniversityNot yet recruitingPRIMARY HYPERTENSIONTurkey (Türkiye)
-
SingHealth PolyclinicsNanyang PolytechnicEnrolling by invitationHypertension,EssentialSingapore
-
Hacettepe UniversityBozok UniversityCompletedHypertension | Arterial Hypertension | Systemic HypertensionTurkey (Türkiye)
-
BackBeat Medical IncNot yet recruitingHypertension, Systolic | Hypertension (HTN) | Heart Failure With Preserved Ejection Fraction (HFpEFGeorgia
-
Xuanwu Hospital, BeijingNot yet recruiting
-
Shenzhen Salubris Pharmaceuticals Co., Ltd.Not yet recruiting
-
Instituto de Cardiologia do Rio Grande do SulCompletedHypertension (HTN) | Hypertension ArterialBrazil